pazopanib: used to treat clear cell variant renal cell carcinoma. Continuing treatment beyond 3-months. This treatment must be the sole tyrosine kinase inhibitor subsidised for this condition
Tablets
4387 EGP
pazopanib: used to treat clear cell variant renal cell carcinoma. Continuing treatment beyond 3-months. This treatment must be the sole tyrosine kinase inhibitor subsidised for this condition
Note: All the provided information about this drug does not substitute for consulting a doctor.